JAK2 and myeloproliferative neoplasm: Studies in the last decade have shown that JAK2/CALR/MPL gene mutations are the driver mutations in MPN.8, 9, 10 Among those, the JAK2V617F mutation is considered the most common driver mutation of MPN and is detected in 95% of PV patients and 60% of ET and PMF patients.11